Sema4 earnings
WebMay 2, 2024 · STAMFORD, Conn., May 02, 2024 -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it has completed the acquisition of GeneDx, LLC (“GeneDx”), a leader in genomic testing and analysis for rare disorders, from OPKO Health, Inc. (Nasdaq: OPK) (“OPKO”). WebApr 9, 2024 · Trellus Management Company LLC lifted its holdings in shares of Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) by 148.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,100,000 shares of the company’s stock after acquiring an additional 657,100 shares during the period. Trellus …
Sema4 earnings
Did you know?
WebNov 16, 2024 · Sema4 Holdings ( NASDAQ:SMFR) Third Quarter 2024 Results Key Financial Results Revenue: US$83.2m (up 93% from 3Q 2024). Net loss: US$77.6m (down by 337% from US$32.7m profit in 3Q 2024). US$0.20...
WebApr 7, 2024 · STAMFORD — GeneDx, the genomic-testing company formerly known as Sema4, is laying off 19 more employees, marking the latest phase of sweeping reductions to the Stamford-based firm’s workforce and operations. ... Chief Executive Officer and President Katherine Stueland said in a statement last month when the company … WebNov 15, 2024 · Sema4 expects full year 2024 total revenue to be in the range of $201 million to $204 million. Fourth quarter resulted volume is expected to be in the range of 73,000 to …
Web1,001-5,000 employees Headquarters Stamford, Connecticut Type Public Company Founded 2024 Specialties disease prevention, machine learning, artificial intelligence, healthcare, digital health,... WebNov 14, 2024 · Our pediatric and rare disease franchise is setting new internal records, generating over 50% revenue growth in the third quarter and delivering over 40% in adjusted gross margin,” said Katherine...
WebEarnings for Sema4 (SMFR) Earnings in 2024 (TTM): -$0.33 B. According to Sema4's latest financial reports the company's current earnings (TTM) are -$0.33 B. In 2024 the company …
WebMar 2, 2024 · Sema4 (NASDAQ:SMFR) has a recorded net income of -$245.39 million. SMFR has generated -$0.93 earnings per share over the last four quarters. What is Sema4's EPS … mclean contractsWebDec 15, 2024 · You can see Sema4 Holdings' historic earnings and revenue below, but keep in mind there's always more to the story. NasdaqGS:SMFR Earnings and Revenue Growth December 15th 2024. lidl tubs with handlesWebSema4 Holdings Corp’s net profit fell -347.14% since last year same period to $-77.58Mn in the Q3 2024. On a quarterly growth basis, Sema4 Holdings Corp has generated 57.81% … lidl treorchyWebJun 21, 2024 · Earnings Estimate Revisions for Sema4 Holdings Corp. This company is expected to earn -$0.76 per share for the fiscal year ending December 2024, which represents a year-over-year change of 73.3%. mclean community center summer campsWebSema4 is a patient-centered predictive health company and a leader in diagnostic testing. The company is founded on the idea that more information, deeper analysis, and … lidl trooper roadWebJul 18, 2024 · SMFR earnings deck The main data points: Testing volumes +27% ex-Covid Women's Health +23% and oncology +159% Revenue $53.9M vs $64.2M in Q1/21 (+6% from Q4/21) Revenue ex-Covid $50.1M vs $48.3M... mclean community center directorWebMay 12, 2024 · Sema4 is reaffirming its previously issued full year 2024 pro forma revenue target of $350 million. The company now expects fiscal year 2024 total revenue to be $305-315 million, reflecting the... mclean coolers